摘要
目的:研究人参白虎汤加减方对四氧嘧啶性糖尿病模型大鼠的
影响,为临床应用和进一步研究人参白虎汤加减方提供客观的实验
和理论依据。
方法:雄性SD大鼠,以四氧嘧啶200mg/kg腹腔注射造模。随
机分组,实验组以人参白虎汤加减方水煎浓缩液高、低剂量灌胃,
对照组以降糖灵灌胃,连续15天。检测大鼠的血糖、C肽、总胆固
醇、甘油三酯、血清免疫球蛋白IgG、IgM和脾重。
结果:1、人参白虎汤加减方能显著降低糖尿病大鼠的血糖,
但对空腹C肽及葡萄糖刺激后2小时C肽的分泌值无影响,与降糖
灵相比无明显差异(P>0.05)。但高剂量的中药治疗能显著提高大
鼠空腹C肽/血糖比值,效果明显优于降糖灵(P<0.05)。
2、人参白虎汤加减方能显著降低大鼠的血清甘油三酯、总胆
固醇含量,效果优于对照药物(P<0.05)。
3、人参白虎汤加减方能显著提高大鼠血清免疫球蛋白IgG、IgM
的含量(P<0.001),增加脾重(P<0.05)。
结论:人参白虎汤加减方能有效地降糖,降脂,提高免疫功能,
对糖尿病有较好的治疗效果,并优于对照组。
Objective: To investigte the influence of RenShenBaihu Based Decoction on
ALLOXAN-induced diabetes mellitus, and provided data for ftirther study and
clinical practice.
Methods: All male rats were given peritoneal injection with ALLOXAN to
induce diabetes mellitus, and were randomly divided into four groups. The rats
Ireated with RSBHBD(given RSBHBD by tansgastric approach) were divided
into two sub-groups: large dose RSBHBD-treated group and small dose
RSBI-LBD-treated group. Some rats were administered phenethyldiguanide as
control. All rats were killed 15 days after baseline to measure blood-glucose, C-
peptide, total cholesterol, triglyceride, serum 1gM and lgG, and wet weight of
Spleen.
Results: 1. Compared with control group, the level of blood-glucose decreased
significantly, but there was no significant difference between RSBHIBD-treated
groups and control group in level of C-peptide both under fasting condifion and
2 hours after glucose stimulation.The ratio of C-peptide and blood-glucose in large
dose RSBL-IBD-treated group was higher than that in control group (P
2.The content of triglyceride and total cholesterol decreased significantly in
RSBI-IBD-treated groups compared with ihose in control group (P
3.The levels of IgG and 1gM were significantly higher in R1-JBI-IBD-treated
groups than those in control group (P 且
increase of Spleen weight in RSBHBD-treated groups compared with that in
control group (P
Conclusions: RSBI-LBD can decrease blood-glucose and blood-lipid, increase
function of immunity system and is potentially effective in treatment for diabetes
mellitus.
引文
1.池芝盛主编.糖尿病学.第一版,北京:人民卫生出版社,1982:145
2.李秀钧,董砚虎,程丽霞等.糖尿痛研究进展—第16届国际糖尿病联盟大会纪要.中华内分泌代谢杂志,1998;14(2):72
3.中华人民共和国卫生部制定发布.中药新药临床研究指导原则.第1辑,1993:215
4.陆付耳,黄光英,钱振坤,等.糖康治疗四氧嘧啶化学性糖尿病的实验研究.中医药研究,1999;15(1):33
5.林丽娟,郭平凡,林方,等.不同剂量四氧嘧啶腹腔注射对大鼠糖尿病模型稳定性的影响.实验动物科学与管理,1999;16(2):18
6.王宏才,程莘农、消渴病名源流 中国中医基础医学杂志,1999;5(5):51
7.Mordes JR. Animal models of diabetes. In Sktler J. ed. Diabetes mellitus. London: York Medical Book. 1981:56
8.Sakural K and Miura T Iron release from ferritin and generation of hydroxyl radical in the reaction system of alloxan with reduced glutathione; A role of ferritin in alloxan toxicity. Chem PharmBull.1988;36(11): 534
9.杨秀伟.四氧嘧啶性糖尿病与自由基反应.《国外医学》内分泌学分册,1994;14(3):144
10.Sandier, S. Kohtqro, A Boquist, L.A. and Nezamis J.E.(1984) Nicotinamide does not protect islet B cell metabolism against alloxan loxicity. Diabetes;(33):937
11.魏英杰,于国忠,张桂芳,等.异搏定对四氧嘧啶损害大鼠胰岛B细胞的保护作用.生理学报,1992;44(2):209
12.蒋渝.糖尿病研究与实验动物.上海实验动物科学,1991;11(3):161
13.蒋渝,周永禄.四氧嘧啶诱发大鼠糖尿病模型的建立.上海实验动物科学,1990;10(2):79
14.刘永玉,毛良,莫启忠.实验性NIDDM大鼠模型.中华内分泌代谢杂志,1990;6(2):112
15.吴敏,季晖,李萍,等.糖克宁对链脲菌素所致糖尿病大鼠降糖机理的研究.南京中医药大学学报,1999;15(1):22
16.张发荣主编.中西医结合糖尿痛治疗学.中国中医药出版社,1998:193
17.蒋渝,尹才渊,周世清.山茱萸降血糖的实验研究.中药药理与临床,1989;5(1):26
18.王秩.C肽研究进展.《国外医学》.内分泌学分册,1996;16(4):169
19.郭常辉.C—肽及其临床应用.重庆医科大学学报,1988;13(2):156
20.胡远辉.C—肽测定的临床意义.上海医学,1980;3(10):43
21.方小正,吕述军,胡新艳,等.C—肽水平测定对糖尿病治疗的意义.放射免疫学杂志,1999;12(1):23
22.Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia, 1985;28:412
23.Mbanya JCN, Thomas TU, Wilknoson, et al. Hypertension and hyperinsulinemia: a relation in diabetes but not in essential hypertension. Lancet, 1988;(1):733
24.李光伟.空腹血清胰岛素/葡萄糖比值作为B细胞功能指数的可能性.中华内分泌代谢杂志,1998;14(4):232
25.顾关云.从知母根茎分得降低血糖的活性聚糖Anema rans A.B.C和D《国外医学》药学分册,1985;12(6):368
26.王靖,葛盛芳,陈琦,等.知母多糖降血糖活性研究.中草药,1996;27(10):605
27.伊藤忠信.石膏的化学和药理作用.《国外医学》中医中药分册,1984;(1):19
28.吴素香.中药复方及中药活性成分降血糖作用的药理和临床研究进展.基层中药杂志,1999;13(3):46
29.王本祥,杨明,金玉莲,等.人参多肽降血糖机制的研究.药学学报,1990;25(10):727
30.包天桐.人参总皂甙对小鼠四氧嘧啶糖尿病的影响.药学学报,1981;16(8):618
31.郭兰忠主编.现代实用中药学.第1版,人民卫生出版社,1999:805
32.李先荣,康永,程霞,等.注射用黄芪多糖药理作用的研究—对血糖及肝糖原含量的影响.中成药,1989;11(9):32
33.张银娣.黄芪皂甙甲对血浆cAMP及再生肝DNA合成的影响.药学学报,1990;13(6):1
34.宁亚功,张鸿恩,林兰.糖尿病夹血瘀的临床研究进展.中医杂志,1991;(8):50
35.朱秉武,徐君杰,戴宝珠,等.糖尿病患者血液流变学和血脂之间关系的探讨.江苏医药,1992;18(4):203
36.池芝盛主编.糖尿病学.第一版,北京:人民卫生出版社,1982:273
37.田牛.微循环基础与临床.第一版,北京:人民军医出版社,1984:250
38.顾士芬,程干银 顾全珍.糖尿病患者的甲皱襞微循环观察.江苏医药,1991;(12):649
39.张镜如主编.生理学.第四版人民卫生出版社,1998:121
40.阴健主编.中药现代研究与临床应用.第一版,学苑出版社,1994:9
41.杨涛,梁康.候纬敏等.四种中药抗白内障形成中晶状体脂类过氧化物水平及脂类含量的变化生物化学杂志,1992;8(2):164
42.阴健主编.中药现代研究与临床应用.第一版,学苑出版社,1994:175
43.王浴生主编.中药药理与应用.第二版,人民卫生出版社,1998:192.251~252.253.432.983.985
44.牟永方,翟逸莉,刘光耀,等.丹参和小剂量醋柳酸预防实验性动脉粥样硬化的初步观察.中华老年医学,1987;6(4):256
45.郭兆贵,许树梧,贾宏钧,等.黄芪的外周扩血管作用及与γ—氨酪酸的比较.中医杂志,1980;21(5):73
46.吴师竹,祈作仁.黄芪多糖的药理作用.中药药理与临床,1989;5(6):26
47.陈灏珠主编.实用内科学.北京:人民卫生出版社,1997:828~836
48.Binz K,Joller PFresh D,et al. Repopulation of the atrophied thymus in diabetic rats by insulinlike growth factor I.Proc Natl Acad Sci USA ,1990;87:3690